Which has grown faster, AUPH or VRDN?

Over the past five years, VRDN grew revenue faster — AUPH at a 40.17% CAGR versus VRDN at 93.92%.

Is AUPH or VRDN more profitable?

AUPH runs the higher net margin — AUPH at 100.84% versus VRDN at -544.06%.

How have AUPH and VRDN total returns compared?

Over the past 10 years, AUPH delivered 14.53% and VRDN delivered -16.41% annualized total return. Past performance doesn't predict future results.

Aurinia Pharmaceuticals Inc. (AUPH) vs Viridian Therapeutics, Inc. (VRDN)

A side-by-side comparison of Aurinia Pharmaceuticals Inc. and Viridian Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AUPH

Aurinia Pharmaceuticals Inc.

$2.02B

$15.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

VRDN

Viridian Therapeutics, Inc.

$2.06B

$18.22HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — AUPH vs VRDN

growth of $100 · dividends reinvested · last 10y

AUPH +288.1% (+14.5%/yr)VRDN -83.3% (-16.4%/yr)AUPH compounded faster over this window

Log scale — wide-divergence pair

AUPH VRDN

AUPH vs VRDN: by the numbers

•VRDN is the larger company ($2.06B vs $2.02B market cap).
•AUPH is profitable (100.84% net margin) while VRDN runs a net loss (-544.06%).
•VRDN grew revenue faster over the past five years (93.92% vs 40.17% CAGR).

Metrics side by side

Valuation

Metric	AUPH	VRDN
P/E ratio	6.85	N/A
Forward P/E	16.62	N/A
P/S ratio	6.48	29.02
P/B ratio	3.28	3.66
EV / EBITDA	11.16	N/A
FCF yield	8.60%	N/A

Profitability

Metric	AUPH	VRDN
Gross margin	90.36%	99.55%
Operating margin	37.06%	-512.91%
Net margin	100.84%	-544.06%
ROE	51.09%	-58.45%
ROIC	21.77%	-39.18%

Growth (annualized)

Metric	AUPH	VRDN
Revenue CAGR (5Y)	40.17%	93.92%
Total return CAGR (5Y)	-5.88%	1.64%

Frequently asked

Which has grown faster, AUPH or VRDN?: Over the past five years, VRDN grew revenue faster — AUPH at a 40.17% CAGR versus VRDN at 93.92%.
Is AUPH or VRDN more profitable?: AUPH runs the higher net margin — AUPH at 100.84% versus VRDN at -544.06%.
How have AUPH and VRDN total returns compared?: Over the past 10 years, AUPH delivered 14.53% and VRDN delivered -16.41% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AUPH analysis Full VRDN analysis Interactive comparison tool

Dig into the metrics

Aurinia Pharmaceuticals P/E ratio Aurinia Pharmaceuticals ROE Viridian Therapeutics ROE Aurinia Pharmaceuticals operating margin Viridian Therapeutics operating margin Aurinia Pharmaceuticals revenue growth Viridian Therapeutics revenue growth Aurinia Pharmaceuticals free cash flow Viridian Therapeutics free cash flow

Aurinia Pharmaceuticals & Viridian Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.